Our researchers work tirelessly to develop novel drugs and revolutionize treatments for chronic illness and drug-resistant diseases, impacting the lives of millions.

COVID-19 has emerged as a global, once-in-a-century pandemic. To halt the spread of the coronavirus and save lives around the world, we wasted no time in collaborating with our fellow institutions to develop innovative technologies to prevent, mitigate, and treat the disease, strengthen health policy and systems, and step up precautionary measures during community outreach. Find out more about our all-round efforts , or watch a video that highlights our key initiatives .

A marine life research team discovered 7,300 new ocean species and a new type of bacteria that have the potential for new antibiotics development, providing new hope to millions of patients suffering from rare diseases.

Brain Cancer image

A drug molecule co-identified by our research team offers hope of longer life to chemo-resistant patients of a rare and deadly type of brain cancer – secondary glioblastoma.

HIV image

An interdisciplinary research group has mapped out the fitness landscape of a crucial protein in HIV by employing a computational framework, potentially paving the way for the design of a vaccine that may force the deadly virus to mutate into forms that destroy it.

Lung Disease image

We are developing an innovative medicine ATYR1923, a potential therapeutic for patients suffering from interstitial lung diseases with no known cure, through clinical development.

The unveiling of the fundamental mechanism that causes schizophrenia and other serious psychiatric conditions may potentially lead to the development of new treatments and drugs for mental disorders.